Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PicoEnz is a biotechnology company specializing in ultra-high-throughput enzyme discovery and optimization using proprietary droplet microfluidics technology. The company's platform enables the screening of millions of enzyme variants in picoliter-sized droplets, significantly accelerating the development of novel biocatalysts for industrial, diagnostic, and therapeutic applications. By miniaturizing assays, PicoEnz reduces costs and timelines associated with traditional protein engineering workflows. The company partners with organizations across the life sciences sector to identify high-performance enzymes with specific functional properties. Their technology is particularly effective for directed evolution and identifying rare variants in large genetic libraries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PicoEnz.